$3.22 Billion is the total value of QVT Financial LP's 77 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | INTEL CORPsdcv 12/1 | $82,656,000 | +130.5% | 60,247,000 | +127.3% | 2.57% | +135.7% | |
| IBB | Buy | ISHARES TRnasdq biotec etf | $68,081,000 | +94.1% | 232,145 | +75.7% | 2.11% | +98.5% |
| AGNPRA | New | ALLERGAN PLCpfd conv ser a | $42,377,000 | – | 50,000 | +100.0% | 1.32% | – |
| KMX | Buy | CARMAX INC | $24,285,000 | +15.2% | 410,089 | +25.3% | 0.75% | +17.8% |
| Buy | HERBALIFE LTDnote 2.000% 8/1 | $24,030,000 | +73.4% | 25,000,000 | +66.7% | 0.75% | +77.2% | |
| KANG | Buy | IKANG HEALTHCARE GROUP INCsponsored adr | $22,788,000 | -6.2% | 1,560,843 | +11.4% | 0.71% | -4.1% |
| ADS | Buy | ALLIANCE DATA SYSTEMS CORP | $21,106,000 | +130.2% | 84,765 | +111.2% | 0.66% | +135.6% |
| GS | Buy | GOLDMAN SACHS GROUP INC | $18,823,000 | +0.9% | 81,940 | +5.1% | 0.58% | +3.2% |
| PYPL | Buy | PAYPAL HLDGS INC | $17,319,000 | +11.1% | 402,573 | +2.0% | 0.54% | +13.7% |
| SBGI | Buy | SINCLAIR BROADCAST GROUP INCcl a | $16,079,000 | +53.3% | 397,023 | +26.3% | 0.50% | +56.4% |
| TWX | New | TIME WARNER INC | $15,782,000 | – | 161,518 | +100.0% | 0.49% | – |
| AGEN | Buy | AGENUS INC | $15,451,000 | -8.4% | 4,098,534 | +0.1% | 0.48% | -6.4% |
| New | NXP SEMICONDUCTORS N Vdbcv 1.000%12/0 | $11,601,000 | – | 10,000,000 | +100.0% | 0.36% | – | |
| RICE | New | RICE ENERGY INC | $11,217,000 | – | 473,300 | +100.0% | 0.35% | – |
| GTN | Buy | GRAY TELEVISION INC | $10,693,000 | +88.7% | 737,454 | +41.2% | 0.33% | +93.0% |
| EURN | Buy | EURONAV NV ANTWERPEN | $10,672,000 | +37.9% | 1,350,924 | +38.8% | 0.33% | +40.9% |
| CALM | New | CAL MAINE FOODS INC | $9,388,000 | – | 255,100 | +100.0% | 0.29% | – |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $6,940,000 | +160.7% | 1,360,647 | +107.0% | 0.22% | +166.7% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $6,562,000 | +12.4% | 221,691 | +4.2% | 0.20% | +15.3% |
| XRT | Buy | SPDR SERIES TRUSTs&p retail etf | $6,444,000 | +23.6% | 152,557 | +29.0% | 0.20% | +26.6% |
| New | PRICELINE GRP INCnote 1.000% 3/1 | $5,426,000 | – | 2,880,000 | +100.0% | 0.17% | – | |
| DHT | Buy | DHT HOLDINGS INC | $5,391,000 | +21.5% | 1,206,051 | +12.5% | 0.17% | +23.7% |
| CASC | New | CASCADIAN THERAPEUTICS INC | $3,312,000 | – | 800,000 | +100.0% | 0.10% | – |
| PFF | New | ISHARES TRu.s. pfd stk etf | $1,981,000 | – | 51,194 | +100.0% | 0.06% | – |
| HYG | New | ISHARES TRiboxx hi yd etf | $1,581,000 | – | 18,014 | +100.0% | 0.05% | – |
| New | VECTOR GROUP LTDfrnt 1/1 | $730,000 | – | 500,000 | +100.0% | 0.02% | – | |
| BIVV | New | BIOVERATIV INC | $320,000 | – | 5,879 | +100.0% | 0.01% | – |
| GLFMQ | New | GULFMARK OFFSHORE INCcl a new | $213,000 | – | 607,500 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.